Business Development


Business Development

We believe that advances in therapeutic and laboratory medicine can be accelerated through collaboration.

Exagen offers the following capabilities:

Business Collaborations

  • Autoimmune rheumatic disease pharmaceutical and diagnostic co-promotion
  • Autoimmune disease biomarker licensing
  • Companion diagnostics
  • Collaboration studies with novel Exagen biomarkers

Clinical Laboratory Services

  • Therapeutic clinical study support
  • Clinical consultations
  • Access to biorepository of well-characterized autoimmune rheumatic disease samples
  • Contract laboratory services

If you have an idea for working with Exagen, or a question about current collaborations please contact Dennis Takasugi, VP of Business Development at 760.560.1529 or Mark Hazeltine, VP of Finance and Corporate Development at 760.477.5523